Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)
Celltrion plans to provide dual treatment options for COVID-19; Regkirona for hospitalised patients and a nebulised cocktail therapy (CT-P63 in combination with Regkirona) for at- home settings
The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound
India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
Subscribe To Our Newsletter & Stay Updated
